PDB36 AN ECONOMIC MODEL OF THE EFFECTS OF QUICK RELEASE BROMOCRIPTINE MESYLATE VERSUS ALTERNATIVE ORAL ANTIDIABETIC DRUGS ON HOSPITALIZATIONS AND COSTS
May 1, 2011, 00:00
10.1016/j.jval.2011.02.544
https://www.valueinhealthjournal.com/article/S1098-3015(11)00683-8/fulltext
Title :
PDB36 AN ECONOMIC MODEL OF THE EFFECTS OF QUICK RELEASE BROMOCRIPTINE MESYLATE VERSUS ALTERNATIVE ORAL ANTIDIABETIC DRUGS ON HOSPITALIZATIONS AND COSTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00683-8&doi=10.1016/j.jval.2011.02.544
First page :
A97
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1109